Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pernille May Hansen

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Acta Ophthalmologica|May 28, 2026
Ocular surface disease in atopic dermatitisPernille May Hansen
Dermatitis : Contact, Atopic, Occupational, Drug|February 24, 2025
Higher Occurrence of Ocular Surface Disease Symptoms in Patients with Atopic Dermatitis: Data from 57,464 Subjects in the FOREVER CohortPernille May Hansen, Jens Rovelt, Josefine Freiberg, et al.
Journal of Optometry|October 3, 2023
Comparing the effect of benzalkonium chloride-preserved, polyquad-preserved, and preservative-free prostaglandin analogue eye drops on cultured human conjunctival goblet cellsAnne Hedengran, Josefine Freiberg, Pernille May Hansen, et al.
The Ocular Surface|May 7, 2026
Proteomic Profiling of Tear Fluid in Patients with Atopic KeratoconjunctivitisLars Iversen, Manuel Ramirez Garrastacho, Pernille May Hansen, et al.
The Ocular Surface|February 27, 2026
Cytokine Levels and Clinical Characteristics in the Tear Fluid of Patients with Atopic Dermatitis and Atopic KeratoconjunctivitisPernille May Hansen, Tor P Utheim, Hans Christian D Aass, et al.
Acta Ophthalmologica|May 9, 2022
Generic benzalkonium chloride-preserved travoprost eye drops are not identical to the branded polyquarternium-1-preserved travoprost eye drop: Effect on cultured human conjunctival goblet cells and their physicochemical propertiesAnne Hedengran, Josefine Clement Freiberg, Pernille May Hansen, et al.
Dermatology (Basel, Switzerland)|September 13, 2025
Dupilumab-Associated Ocular Surface Disease in Patients with Atopic Dermatitis Is Frequent: A Nationwide Real-World Evidence StudyAne Marie Hovmand Nøhr, Pernille May Hansen, Michael Møller-Hansen, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Acta Ophthalmologica|May 28, 2026
Ocular surface disease in atopic dermatitisPernille May Hansen
Dermatitis : Contact, Atopic, Occupational, Drug|February 24, 2025
Higher Occurrence of Ocular Surface Disease Symptoms in Patients with Atopic Dermatitis: Data from 57,464 Subjects in the FOREVER CohortPernille May Hansen, Jens Rovelt, Josefine Freiberg, et al.
Journal of Optometry|October 3, 2023
Comparing the effect of benzalkonium chloride-preserved, polyquad-preserved, and preservative-free prostaglandin analogue eye drops on cultured human conjunctival goblet cellsAnne Hedengran, Josefine Freiberg, Pernille May Hansen, et al.
The Ocular Surface|May 7, 2026
Proteomic Profiling of Tear Fluid in Patients with Atopic KeratoconjunctivitisLars Iversen, Manuel Ramirez Garrastacho, Pernille May Hansen, et al.
The Ocular Surface|February 27, 2026
Cytokine Levels and Clinical Characteristics in the Tear Fluid of Patients with Atopic Dermatitis and Atopic KeratoconjunctivitisPernille May Hansen, Tor P Utheim, Hans Christian D Aass, et al.
Acta Ophthalmologica|May 9, 2022
Generic benzalkonium chloride-preserved travoprost eye drops are not identical to the branded polyquarternium-1-preserved travoprost eye drop: Effect on cultured human conjunctival goblet cells and their physicochemical propertiesAnne Hedengran, Josefine Clement Freiberg, Pernille May Hansen, et al.
Dermatology (Basel, Switzerland)|September 13, 2025
Dupilumab-Associated Ocular Surface Disease in Patients with Atopic Dermatitis Is Frequent: A Nationwide Real-World Evidence StudyAne Marie Hovmand Nøhr, Pernille May Hansen, Michael Møller-Hansen, et al.
Pageof 1